Literature DB >> 17646929

The VEGFR2 and PKA pathways converge at MEK/ERK1/2 to promote survival in serum deprived neuronal cells.

Evan Gomes1, Luena Papa, Tianfeng Hao, Patricia Rockwell.   

Abstract

Identifying prosurvival mechanisms in stressed neuronal cells would provide protective strategies to hinder neurodegeneration. Recent evidence shows that vascular endothelial growth factor (VEGF), a well-established mitogen in endothelial cells, can mediate neuroprotection against damaging insults through the activation of its cognate receptor VEGFR2. In addition, growth factor receptor signaling pathways have been shown to crosstalk with cAMP-dependent Protein Kinase A (PKA) to protect neuronal cells from harmful stimuli. Whether a relationship exists between VEGFR2 and PKA in mediating neuroprotection under stressful conditions is unknown. Using SK-N-SH neuronal cells as a model system, we show that serum deprivation induces an upregulation in VEGF and VEGFR2 that concomitantly serves as a prosurvival signaling pathway. Inhibitor studies revealed that PKA functioned concurrently with VEGFR2 pathway to signal the activation of the extracellular signal-regulated protein kinases (ERK1/2) as protection against caspase-3/7 activation and a subsequent cell death. The loss in cell viability induced by VEGFR2 and PKA inhibition was prevented by caspase inhibition or overexpression of ERK1. Overexpression of the antiapoptotic protein Bcl-xL also promoted survival when VEGFR2 function was blocked. However, the protection elicited by all three treatments were prevented by the inclusion of a selective inhibitor of mitogen-activated protein kinase kinase (MEK), the upstream kinase that activates ERK1/2. Taken together, these findings suggested that PKA and VEGFR2 converge at the MEK/ERK1/2 pathway to protect serum starved neuronal cells from a caspase-dependent cell death.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17646929     DOI: 10.1007/s11010-007-9542-2

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  41 in total

1.  Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines.

Authors:  T Putz; Z Culig; I E Eder; C Nessler-Menardi; G Bartsch; H Grunicke; F Uberall; H Klocker
Journal:  Cancer Res       Date:  1999-01-01       Impact factor: 12.701

2.  Vascular endothelial growth factor overexpression delays neurodegeneration and prolongs survival in amyotrophic lateral sclerosis mice.

Authors:  Yaoming Wang; Xiao Ou Mao; Lin Xie; Surita Banwait; Hugo H Marti; David A Greenberg; Kunlin Jin
Journal:  J Neurosci       Date:  2007-01-10       Impact factor: 6.167

3.  PACAP protects neuronal differentiated PC12 cells against the neurotoxicity induced by a mitochondrial complex I inhibitor, rotenone.

Authors:  Gang Wang; Chen Qi; Guo-Hua Fan; Hai-Yan Zhou; Sheng-Di Chen
Journal:  FEBS Lett       Date:  2005-07-18       Impact factor: 4.124

Review 4.  The neuropilins: multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis.

Authors:  Gera Neufeld; Tzafra Cohen; Niva Shraga; Tali Lange; Ofra Kessler; Yael Herzog
Journal:  Trends Cardiovasc Med       Date:  2002-01       Impact factor: 6.677

5.  Vascular endothelial growth factor rescues HN33 neural cells from death induced by serum withdrawal.

Authors:  K L Jin; X O Mao; D A Greenberg
Journal:  J Mol Neurosci       Date:  2000-06       Impact factor: 3.444

6.  Human vascular endothelial growth factor protects axotomized retinal ganglion cells in vivo by activating ERK-1/2 and Akt pathways.

Authors:  Ulkan Kilic; Ertugrul Kilic; Anne Järve; Zeyun Guo; Annett Spudich; Katja Bieber; Uxue Barzena; Claudio L Bassetti; Hugo H Marti; Dirk M Hermann
Journal:  J Neurosci       Date:  2006-11-29       Impact factor: 6.167

7.  Mechanism of protein kinase B activation by cyclic AMP-dependent protein kinase.

Authors:  N Filippa; C L Sable; C Filloux; B Hemmings; E Van Obberghen
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

8.  Mitogen-activated protein kinase/extracellular signal-regulated kinase attenuates 3-hydroxykynurenine-induced neuronal cell death.

Authors:  Hyun Jung Lee; Jae-Hyung Bach; Hee-Sun Chae; Sang Hyung Lee; Wan Seok Joo; Se Hoon Choi; Kyung Yong Kim; Won Bok Lee; Sung Su Kim
Journal:  J Neurochem       Date:  2004-02       Impact factor: 5.372

Review 9.  Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation.

Authors:  Philip J S Stork; John M Schmitt
Journal:  Trends Cell Biol       Date:  2002-06       Impact factor: 20.808

Review 10.  Mechanisms of regulating the Raf kinase family.

Authors:  Huira Chong; Haris G Vikis; Kun-Liang Guan
Journal:  Cell Signal       Date:  2003-05       Impact factor: 4.315

View more
  13 in total

Review 1.  Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.

Authors:  Eugene J Barrett; Zhenqi Liu; Mogher Khamaisi; George L King; Ronald Klein; Barbara E K Klein; Timothy M Hughes; Suzanne Craft; Barry I Freedman; Donald W Bowden; Aaron I Vinik; Carolina M Casellini
Journal:  J Clin Endocrinol Metab       Date:  2017-12-01       Impact factor: 5.958

2.  Crosstalk between VEGFR2 and muscarinic receptors regulates the mTOR pathway in serum starved SK-N-SH human neuroblastoma cells.

Authors:  Jacob Edelstein; Tianfeng Hao; Qin Cao; Leon Morales; Patricia Rockwell
Journal:  Cell Signal       Date:  2010-09-16       Impact factor: 4.315

3.  Multi-targeted neuroprotection by the HSV-2 gene ICP10PK includes robust bystander activity through PI3-K/Akt and/or MEK/ERK-dependent neuronal release of vascular endothelial growth factor and fractalkine.

Authors:  Jennifer M Laing; Cynthia C Smith; Laure Aurelian
Journal:  J Neurochem       Date:  2009-11-05       Impact factor: 5.372

4.  p38 MAPK as a negative regulator of VEGF/VEGFR2 signaling pathway in serum deprived human SK-N-SH neuroblastoma cells.

Authors:  Evan Gomes; Patricia Rockwell
Journal:  Neurosci Lett       Date:  2007-12-15       Impact factor: 3.046

5.  Signaling through the vascular endothelial growth factor receptor VEGFR-2 protects hippocampal neurons from mitochondrial dysfunction and oxidative stress.

Authors:  Tianfeng Hao; Patricia Rockwell
Journal:  Free Radic Biol Med       Date:  2013-05-31       Impact factor: 7.376

6.  Using dynamic gene module map analysis to identify targets that modulate free fatty acid induced cytotoxicity.

Authors:  Zheng Li; Shireesh Srivastava; Robert Findlan; Christina Chan
Journal:  Biotechnol Prog       Date:  2007-12-04

7.  VEGF-A165b is an endogenous neuroprotective splice isoform of vascular endothelial growth factor A in vivo and in vitro.

Authors:  Nicholas Beazley-Long; Jing Hua; Thomas Jehle; Richard P Hulse; Rick Dersch; Christina Lehrling; Heather Bevan; Yan Qiu; Wolf A Lagrèze; David Wynick; Amanda J Churchill; Patrick Kehoe; Steven J Harper; David O Bates; Lucy F Donaldson
Journal:  Am J Pathol       Date:  2013-07-06       Impact factor: 4.307

8.  VEGF-A is necessary and sufficient for retinal neuroprotection in models of experimental glaucoma.

Authors:  Richard H Foxton; Arthur Finkelstein; Sauparnika Vijay; Annegret Dahlmann-Noor; Peng T Khaw; James E Morgan; David T Shima; Yin-Shan Ng
Journal:  Am J Pathol       Date:  2013-02-12       Impact factor: 4.307

9.  Transcriptional landscapes at the intersection of neuronal apoptosis and substance P-induced survival: exploring pathways and drug targets.

Authors:  S Paparone; C Severini; M T Ciotti; V D'Agata; P Calissano; S Cavallaro
Journal:  Cell Death Discov       Date:  2016-08-01

10.  Pathway analysis reveals common pro-survival mechanisms of metyrapone and carbenoxolone after traumatic brain injury.

Authors:  Helen L Hellmich; Daniel R Rojo; Maria-Adelaide Micci; Stacy L Sell; Deborah R Boone; Jeanna M Crookshanks; Douglas S DeWitt; Brent E Masel; Donald S Prough
Journal:  PLoS One       Date:  2013-01-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.